Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02227680
Other study ID # H-32796
Secondary ID
Status Completed
Phase N/A
First received August 21, 2014
Last updated January 27, 2015
Start date July 2014
Est. completion date January 2015

Study information

Verified date January 2015
Source Boston Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This project studies the feasibility of (1) implementing massage therapy and music therapy onto a busy medical inpatient unit at Boston Medical Center, and (2) evaluating massage therapy and music therapy's impact on patient satisfaction, patient outcomes, and cost. The investigators will conduct a randomized controlled trial comparing massage therapy, music therapy, and usual care to collect preliminary data on critical outcomes for patients (satisfaction, symptom control) and for the hospital (pain medication use and length of stay, both critical drivers of cost). The investigators anticipate using these preliminary data to apply for a future larger and longer adequately powered randomized controlled trial to definitively answer the following research questions: does implementation of an inpatient massage therapy and/or music therapy service (a) improve patient satisfaction; (b) reduce symptoms such as pain; and (c) lower health care costs through less pain medication and reduced length of stay?


Description:

This randomized controlled trial compares massage therapy to usual care and music therapy to usual care for patients admitted to the Family Medicine Inpatient Unit of Boston Medical Center. Ninety family medicine inpatients will be recruited by the research assistant to participate in the study. Participants will be randomized directly following consent in a 1:1:1 ratio to massage therapy, music therapy, or usual care. Individuals assigned to the usual care group will receive the choice of a massage voucher for one massage at Boston Medical Center's Integrative Medicine program or a music therapy CD following completion of the study.

Treatment assignments will be prepared by the study biostatistician, using a permuted block method with varying block sizes of 3, 6, and 9, prior to the start of the study. These will be sealed in sequentially numbered opaque envelopes. This order will not be changed. A research assistant will take a randomization envelope, in sequential order, and read the treatment assignment to the participant following enrollment.

After enrollment and randomization is complete each day, the massage therapist and music therapist will begin to see participants for treatment. Treatments will take place in the inpatient hospital room. Curtains will be pulled closed to maintain privacy in rooms that have two beds. Both music and massage therapists will be present Monday-Sunday to provide treatment to participants.

Treatments will be attempted 1-3 times per day for the duration of the participant's stay on the unit, based on the participant's availability (they may be scheduled for diagnostic tests, imaging, consults, etc). The music and massage therapists will work down the list of participants, visiting each one by one and administering treatment (details below for each therapy). If a participant is not available at the time the therapist comes by, he/she will revisit the participant after they have gone through their list and administered treatments. Once the therapist has provided the therapy once to every patient on his/her list, he/she will begin at the top of the list and provide a second round of treatments, and repeat again for a third round as time permits.

The music therapist and massage therapist will create a note sheet each day for each participant. This will allow them to track number of treatments as well as any comments relevant to treatment (patient preferences, etc). A research assistant will collect these at the end of each day, enter them into the secure online database, and store them in a locked file cabinet.

The music therapist and massage therapist will each be given an updated list of patients to treat (first name, last initial, room number) each morning. These lists (separated by treatment group) will include the newly enrolled and randomized participants as well as those who have not yet been discharged. At the end of each day, the therapists will report to the research assistant on how many sessions were provided to each participant.

When the research assistant notes that a participant has been discharged, he/she has approximately 7 days to contact the patient (by phone or email) to administer the endline survey. Then, thirty days after discharge, the research assistant will check the participant's electronic medical record to see if he/she has been admitted again since discharge. Participants in the control group, following discharge and completion of the endline survey, will be mailed either a music/meditation CD or a voucher for massage at BMC, according to their preference.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date January 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or older

- Inpatient on the Boston Medical C enter Family Medicine inpatient service

Exclusion Criteria:

- Inability to provide informed consent

- Contagious skin disease or infection

- Hemophilia

- Thrombocytopenia

- Encephalopathy

- Dementia

- Altered mental status

- 1:1 status (requiring constant supervision)

- Any condition, as determined by the attending physician, which would prevent participation in the study.

- Observation status

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Music Therapy
Each music therapy session will begin with a brief description of the protocol, a musical introduction, a discussion of music preferences, and an informal assessment of participant needs to determine target goals, e.g., management of pain, anxiety, and other symptoms; breath control; emotional support and regulation. After the initial visit, the music therapist will create a playlist, based on participant preferences, and burn it onto a CD for the participant. The participant will be encouraged to use the book and listen to the CDs as often as he/she would like. After the initial visit, follow up visits will include techniques like music-facilitated breathing, music and imagery, music and relaxation/meditation, song writing, improvisation, singing, lyric substitution, lyric analysis, musical reminiscence, passive listening. There will be the opportunity to create music and write songs across multiple sessions, if these activities are indicated.
Massage Therapy
Working with experts in hospital-based massage therapy, we have developed a semi-standardized inpatient massage protocol that utilizes Swedish techniques and acupressure. The protocol was adapted from our successful previous study of massage for perioperative care of patients undergoing implantation of permanent intravenous access devices. Massage therapists will focus on hands, feet, arms, and neck, as able, during the treatments.

Locations

Country Name City State
United States Boston Medical Center Boston Massachusetts

Sponsors (3)

Lead Sponsor Collaborator
Boston Medical Center Berklee College of Music, Muscular Therapy Institute Foundation, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient satisfaction Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey questions within 7 days after discharge No
Secondary Pain medication use Administration of pain medication is documented in the electronic medical record each time a dose is given. We will use the EMR to document number of doses and amount (mg) of each dose during the participant's stay. duration of hospital stay, an expected average of 4 days No
Secondary Sedative use Administration of sedatives is documented in the electronic medical record each time a dose is given. We will use the EMR to document number of doses and amount (mg) of each dose during the participant's stay. duration of hospital stay, an expected average of 4 days No
Secondary Length of stay duration of hospital stay, an expected average of 4 days No
Secondary Number of re-admissions 30 days after initial discharge 30 days post-discharge No
Secondary Pain level Pain levels are documented for every patient by nurses on a daily basis. We will utilize the electronic medical record (EMR) and document every pain evaluation (0-10 point scale of current pain intensity) performed by nurses on inpatient unit during participant's stay. duration of hospital stay, an expected average of 4 days No
See also
  Status Clinical Trial Phase
Recruiting NCT05016947 - Venetoclax Plus Inotuzumab for B-ALL Phase 1
Recruiting NCT05009537 - Optical Genome Mapping in Hematological Malignancies
Terminated NCT01230788 - Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia N/A
Completed NCT00333190 - CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation N/A
Recruiting NCT05461625 - ACL Reconstruction With/Without ALL Reconstruction N/A
Recruiting NCT02990572 - Amish/Mennonite Research Contact Registry
Completed NCT02631993 - Photochemotherapy and Graft-versus-leukemia in Acute-leukemia N/A
Completed NCT00863148 - Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) Phase 2
Recruiting NCT04601584 - GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL Phase 1/Phase 2
Not yet recruiting NCT05592470 - commd7 Gene Expression in ALL
Recruiting NCT02861209 - Collaborative Network to Take Responsibility for Oral Anticancer Therapy N/A
Completed NCT01012492 - Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT Phase 2
Recruiting NCT04644016 - Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders Phase 2
Recruiting NCT06131801 - Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting NCT05476770 - Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies Phase 1
Recruiting NCT03571321 - Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia Phase 1
Recruiting NCT05414162 - Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Active, not recruiting NCT03154346 - Project Baseline Health Study
Terminated NCT01532635 - A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Phase 2
Completed NCT01319864 - POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Phase 1